FNA Stock Price, Chart, Stats & News

Paragon 28, Inc.
Save
1.10B
Market cap
–
Current P/E
–
Forward P/E
FNA chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 73.46% |
Operating margin | -11.10% |
Pretax margin | -16.93% |
Net margin | -17.50% |
Effective tax rate | -3.36% |
ROA | -8.07% |
ROE | -17.38% |
D/E | 0.85x |
Interest coverage ratio | -2.48x |
FNA valuation
P/E | – |
P/S | 8.19x |
P/B | 8.35x |
P/CF | -184.03x |
P/FCF | -84.91x |
P/OCF | -184.03x |
PEG | -3.13x |
EV multiple | -145.57x |
About
Paragon 28, Inc. is a medical device company specializing in the development, manufacturing, and global distribution of advanced surgical systems tailored for foot and ankle procedures. Its comprehensive product portfolio encompasses a wide array of solutions: Plating Systems: This includes the Gorilla plating series, offering specific solutions for Lisfranc injuries, Lapidus procedures, lateral column corrections, calcaneus slides, and naviculocuneiform (NC) fusions. Complementary products like Baby Gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates, as well as Silverback plating systems, are also available.
Similar securities
Based on sector and market capitalization
Report issue











